Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Interindividual variation of plasma haloperidol concentrations and the impact of concomitant medications: the analysis of therapeutic drug monitoring data.

Therapeutic drug monitoring - 1 Feb 1999

Hirokane G, Someya T, Takahashi S, Morita S, Shimoda K

Abstract excerpt

We analyzed therapeutic drug monitoring (TDM) data from 231 schizophrenic inpatients (137 men, 94 women) and investigated interindividual differences of plasma haloperidol (HAL) concentrations and drug/drug interactions between HAL and various concomitant drugs. Plasma HAL concentrations were determined by an enzyme immunoassay (EIA) method. Plasma HAL concentrations per daily dose of HAL per body weight (HAL C/D...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antimanic Agents
Share to Antipsychotic Agents

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Carbamazepine

Share to Drug Interactions

Share to Drug Monitoring

Share to Haloperidol

Share to Immunoenzyme Techniques

Share to Schizophrenia

Source

Identifiers

PMID: 10051058
DOI: 10.1097/00007691-199902000-00012

Genes

HAL

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Interindividual variation of plasma haloperidol concentrations and the impact of concomitant medications: the analysis of therapeutic drug monitoring data.PMID 10051058Read ↗

Effects of smoking, CYP2D6 genotype, and concomitant drug intake on the steady state plasma concentrations of haloperidol and reduced haloperidol in schizophrenic inpatients.Semantic proximity Read ↗

Importance of the cytochrome P450 2D6 genotype for the drug metabolic interaction between chlorpromazine and haloperidol.Semantic proximity Read ↗

Possible biomarkers modulating haloperidol efficacy and/or tolerability.Semantic proximity Read ↗

Effects of smoking and cytochrome P450 2D6*10 allele on the plasma haloperidol concentration/dose ratio.Semantic proximity Read ↗

CYP2D6*10 alleles are not the determinant of the plasma haloperidol concentrations in Asian patients.Semantic proximity Read ↗

Outliers on the dose-response curve: how to minimize this problem using therapeutic drug monitoring, an underutilized tool in psychiatry.Semantic proximity Read ↗

Plasma concentrations of haloperidol are related to CYP2D6 genotype at low, but not high doses of haloperidol in Korean schizophrenic patients.Semantic proximity Read ↗

Effects of various factors including the CYP2D6 genotype and coadministration of flunitrazepam on the steady-state plasma concentrations of bromperidol and its reduced metabolite.Semantic proximity Read ↗

Effects of age and the CYP2D6*10 allele on the plasma haloperidol concentration/dose ratio.Semantic proximity Read ↗

Thioridazine inhibits risperidone metabolism: a clinically relevant drug interaction.Semantic proximity Read ↗

Dextromethorphan phenotyping and haloperidol disposition in schizophrenic patients.Semantic proximity Read ↗

Effects of the CYP2D6*10 allele on the steady-state plasma concentrations of haloperidol and reduced haloperidol in Japanese patients with schizophrenia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.